CN104829514B - 一种药物中间体的合成方法 - Google Patents
一种药物中间体的合成方法 Download PDFInfo
- Publication number
- CN104829514B CN104829514B CN201510238519.8A CN201510238519A CN104829514B CN 104829514 B CN104829514 B CN 104829514B CN 201510238519 A CN201510238519 A CN 201510238519A CN 104829514 B CN104829514 B CN 104829514B
- Authority
- CN
- China
- Prior art keywords
- compound
- dropping
- completion
- reaction
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510238519.8A CN104829514B (zh) | 2015-05-12 | 2015-05-12 | 一种药物中间体的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510238519.8A CN104829514B (zh) | 2015-05-12 | 2015-05-12 | 一种药物中间体的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104829514A CN104829514A (zh) | 2015-08-12 |
CN104829514B true CN104829514B (zh) | 2017-10-03 |
Family
ID=53807761
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510238519.8A Active CN104829514B (zh) | 2015-05-12 | 2015-05-12 | 一种药物中间体的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104829514B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105130869B (zh) * | 2015-09-07 | 2017-12-26 | 曾伟 | 一种Entresto中间体(S)‑5‑(联苯‑4‑羰基)吡咯烷‑2‑酮的合成方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4248884A (en) * | 1978-09-22 | 1981-02-03 | Pharmindustrie | 2-Pyrrolidine methanol derivatives utilizable as medicaments |
CN101631765A (zh) * | 2007-01-12 | 2010-01-20 | 诺瓦提斯公司 | 用于制备5-联苯基-4-氨基-2-甲基戊酸的方法 |
CN103420888A (zh) * | 2013-08-13 | 2013-12-04 | 张家港威胜生物医药有限公司 | 一种关于l-焦谷氨酸薄荷酯的制备方法 |
-
2015
- 2015-05-12 CN CN201510238519.8A patent/CN104829514B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4248884A (en) * | 1978-09-22 | 1981-02-03 | Pharmindustrie | 2-Pyrrolidine methanol derivatives utilizable as medicaments |
CN101631765A (zh) * | 2007-01-12 | 2010-01-20 | 诺瓦提斯公司 | 用于制备5-联苯基-4-氨基-2-甲基戊酸的方法 |
CN103420888A (zh) * | 2013-08-13 | 2013-12-04 | 张家港威胜生物医药有限公司 | 一种关于l-焦谷氨酸薄荷酯的制备方法 |
Non-Patent Citations (2)
Title |
---|
STUDIES ON PYRROLIDINONES. AN IMPROVED SYNTHESIS OF PYROGLUTAMOYL CHLORIDE;Benoit Rigo,等;《SYNTHETIC COMMUNICATIONS》;19941231;第24卷(第18期);2597-2607 * |
匹多莫德的合成;胡昆,等;《中国医药工业杂志》;20091231;第40卷(第12期);第883-884页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104829514A (zh) | 2015-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106928055B (zh) | 一种采用胆碱类低共熔溶剂催化合成阿司匹林的方法 | |
US9951000B2 (en) | Florfenicol synthesizing method | |
CN106883216A (zh) | 一种奥希替尼的制备方法 | |
CN105294653B (zh) | 富马酸沃诺拉赞的制备工艺 | |
CN107235958A (zh) | 一种制备PARP抑制剂Niraparib的合成方法 | |
CN105566215B (zh) | 一种瑞戈非尼的制备方法 | |
CN104098580B (zh) | 一种阿塞那平关键中间体的制备方法 | |
CN107325082B (zh) | 一种高纯度阿法替尼的制备方法 | |
CN104829514B (zh) | 一种药物中间体的合成方法 | |
CN105481856B (zh) | 一种帕利哌酮的制备方法 | |
CN102816077A (zh) | 乌洛托品作为催化剂在合成氨甲苯酸中的应用 | |
CN111909088B (zh) | 利用BTC/Ph3PO氯代体系制备异喹啉类盐酸盐中间体及Rho激酶抑制剂的方法 | |
CN106632244A (zh) | 一种制备抗癌药物Niraparib的新型合成方法 | |
CN105566260B (zh) | 一种呋塞米的制备方法 | |
CN101519407B (zh) | 一种可具有取代基的环酸酐的合成方法 | |
CN104829588B (zh) | 一种苯并[b]噻吩的制备方法及其中间体 | |
CN104151396B (zh) | 混合溶剂中催化合成s‑乙酰基‑l‑谷胱甘肽的方法 | |
CN106146485B (zh) | 一种制备泰地唑胺的方法及其得到的泰地唑胺结晶体 | |
CN104557877A (zh) | 一种阿伐那非中间体及其制备方法和应用 | |
CN103408542B (zh) | 一种高纯度的达沙替尼无水物的制备方法 | |
CN107739342B (zh) | 一种一步合成5-二芳氨基苯并咪唑酮衍生物的方法 | |
CN102391170B (zh) | 一种n,n-二烯丙基-5-甲氧基色胺盐酸盐的制备方法 | |
CN105541711B (zh) | 一种孟鲁司特的制备方法 | |
JP5501054B2 (ja) | 3,3−ジアミノアクリル酸(1−ジフェニルメチルアゼチジン−3−イル)エステル酢酸塩の製造方法 | |
CN105622520A (zh) | 一种治疗非小细胞肺癌药物色瑞替尼(Ceritinib)的新中间体及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190508 Address after: 224500 North Side of Zhongshan 4th Road, Coastal Industrial Park, Binhai County Economic Development Zone, Yancheng City, Jiangsu Province Patentee after: Jiangsu letter Pharmaceutical Co., Ltd. Address before: 210 000 32 blocks, 699-18 Xuanwu Avenue, Nanjing, Jiangsu Province Patentee before: Jiangsu Fu Rui biological medicine company limited |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220414 Address after: 223800 No. 5, Yanshan Road, ecological Chemical Technology Industrial Park, Sucheng District, Suqian City, Jiangsu Province Patentee after: Jiangsu alpha Pharmaceutical Co.,Ltd. Address before: 224500 North Side of Zhongshan 4th Road, Coastal Industrial Park, Binhai County Economic Development Zone, Yancheng City, Jiangsu Province Patentee before: JIANGSU OUXIN PHARMACEUTICAL CO.,LTD. |